SCHEMBL19863054

SCHEMBL19863054

c1ccc(-n2c3ccccc3c3c4oc5ccccc5c4cc(-c4ccc5c(c4)C4(c6ccccc6-c6ccccc64)c4ccccc4-5)c32)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.34
ALDH1A1 P00352 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
HSD17B10 Q99714 2/20 0.34
POLB P06746 1/20 0.34
TSHR P16473 1/20 0.34
BRCA1 P38398 1/20 0.34
KDM4E B2RXH2 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
ATM Q13315 1/20 0.31
PPARG P37231 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
NR2E3 Q9Y5X4 1/20 0.31
NCOR2 Q9Y618 1/20 0.31
CYP3A4 P08684 1/20 0.30
ALPI P09923 1/20 0.30
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30
PKM P14618 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19863048 0.95 ALOX5 (0.33) ALOX5ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL19863050 0.92 ALOX5 (0.34) ALOX5ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL18594112 0.90 ALOX5 (0.33) ALOX5ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL19863043 0.87 ALOX5 (0.33) ALOX5ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL18594322 0.87 ALOX5 (0.32) ALOX5ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL19862875 0.84 ALOX5 (0.33) ALOX5
SCHEMBL19862870 0.84 ALDH1A1 (0.38) ALOX5ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL19862871 0.83 KDM4E (0.41) ALOX5ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL19862861 0.83 KDM4E (0.41) ALOX5ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL19862879 0.83 KDM4E (0.30) ALOX5KDM4EL3MBTL1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 ALOX5 1089/4885ALDH1A1 242/4885MEN1 798/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 ALOX5 1089/4885ALDH1A1 242/4885MEN1 798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.